Home » Topics » BioWorld Science

BioWorld Science
RSS

European Commission approves Xeljanz for active psoriatic arthritis

June 29, 2018

Researchers present preclinical data for [11C]NOP-46

June 29, 2018

Kymab to test KY-1044 in combination with atezolizumab in clinical trials

June 29, 2018

Melinta Therapeutics describes leads from the pyrrolocytosine class of antibiotics

June 29, 2018

Akebia Therapeutics and Keryx Biopharmaceuticals sign definitive merger agreement

June 29, 2018

Efficacy unclear in study of mutated IDH1 peptide vaccine in patients with gliomas

June 29, 2018

Enrollment begins in phase IIa study of CC-31244 for the treatment of HCV-infected individuals

June 29, 2018

Preliminary data presented from the PIVOT-02 study of NKTR-214 plus nivolumab

June 29, 2018

Erimos Pharmaceuticals initiates phase I study of oral terameprocol

June 29, 2018

Inovio reports phase I results for INO-4700 in MERS

June 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...